ovarian-cancer

Documents about ovarian-cancer

• SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care#893970ClinicalTrials.gov
• Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial#804069ClinicalTrials.gov
• Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies#897169ClinicalTrials.gov
• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA#67893ClinicalTrials.gov
• Hula, a Physical Activity Intervention for Female-Cancer Survivors#890741ClinicalTrials.gov
• Study Evaluating Safety, Tolerability, and Metabolism of Niraparib#405252ClinicalTrials.gov
• Extended Follow-up of Columbia, MO Serum Bank Participants#908824ClinicalTrials.gov
• Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study#291637HAL (France)
• Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx#300638Figshare
• Lymphovascular space invasion as a prognostic factor of epithelial ovarian cancer: a multicenter study by the FRANCOGYN group#350758HAL (France)
• Response: Comment on searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers#652996IRIS
• Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy#665191HAL (France)
• The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study#807400ClinicalTrials.gov
• Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)#831741ClinicalTrials.gov
• Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment#868855ClinicalTrials.gov
• Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses#889054ClinicalTrials.gov
• A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#853703ClinicalTrials.gov
• A review of ovarian-adnexal reporting and data system and radiomics in ovarian cancer: focus on ultrasound applications.#469181NCBI PubMed Central
• Prospective Study of Detection of Sarcopenia in Clinical Practice for Patient With Ovarian or Endometrial Cancer#840018ClinicalTrials.gov
• Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery#862327ClinicalTrials.gov
• Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma#900742ClinicalTrials.gov
• ITIL-306 in Advanced Solid Tumors#226274ClinicalTrials.gov
• Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers#867729ClinicalTrials.gov
• Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#261525ClinicalTrials.gov
• Study of Intermittent OSI-906 Dosing#892210ClinicalTrials.gov
• Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study#872993ClinicalTrials.gov
• Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980–2023) with focus on younger women (0–49 years old)#818564HAL (France)
• Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)#908850ClinicalTrials.gov
• Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer#899981ClinicalTrials.gov
• PRO1107 in Patients With Advanced Solid Tumors#852344ClinicalTrials.gov
• A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers#307324ClinicalTrials.gov
• Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion#683069ClinicalTrials.gov
• Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer#852772ClinicalTrials.gov
• Continuation of Follow-up of DES-Exposed Cohorts#864366ClinicalTrials.gov
• Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#146475ClinicalTrials.gov
• PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#172288ClinicalTrials.gov
• The New Era of Intraperitoneal Carboplatin in Ovarian Cancer: From Biological Rationale to Clinical Implementation#465457OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy#916555ClinicalTrials.gov
• OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy#879411ClinicalTrials.gov
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer#844366ClinicalTrials.gov
• IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence#350006ClinicalTrials.gov
• Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer#387155ClinicalTrials.gov
• A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED)#881836ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer#398184ClinicalTrials.gov
• A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab#868698ClinicalTrials.gov
• Molecular pathogenesis of endometrial and ovarian cancer#129206PMC Full-Text (OAI)
• Investigating Novel Therapeutic Strategies in High Grade Serous Ovarian Cancer#269016MURAL
• Mobile Phone Technology to Increase Genetic Counseling#870509ClinicalTrials.gov
• Connected Prehabilitation Program During Neo Adjuvant Chemotherapy#875127ClinicalTrials.gov
• Patient-Derived Organoids Functionally Stratify Epithelial Ovarian Cancer into Clinically Relevant Chemotherapy Response Phenotypes#429570bioRxiv / medRxiv